YCBD

Cbdmd Inc

0.4680

+0.0090+1.96%

After Hours: 0.4698 +0.0018 +0.38%16:13 09/25 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.3998/0.4070

TODAY RANGE0.3800-0.4099

VOL74.05K

MARKET CAP4.42M

52 WEEK RANGE0.3800-2.560

AVG VOL (3M)434.36K

% TURNOVER0.66%

TURNOVER--

P/E (TTM)-1.2781

% RANGE7.29%

EPS(TTM)-0.3089

P/E(FORWARD)-1.1964

P/B0.5345

BVPS0.7386

DIVIDEND--

P/S0.1834

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP3.98M

SHARES OUTSTANDING11.21M

NEXT EARNINGS--

FREE FLOAT10.08M

LOT SIZE1

EX-DATE05/07/2025

News

Press Releases

Financial Reports

Profile

TipRanks·09/04 15:30
Analysts’ Opinions Are Mixed on These Healthcare Stocks: cbdMD (YCBD) and Ionis Pharmaceuticals (IONS)
NASDAQ·09/04 14:09
Weekly Buzz: IONS, MIST, BIIB, AZN Win Nods; TCRX, NVS Cut Jobs; OVID, VIR Data; REGN, PASG Deals
Seeking Alpha·09/02 12:10
cbdMD agrees to acquire Twinlab Brands
TipRanks·09/02 11:58
cbdMD to Acquire Twinlab Brands, Expanding Wellness Platform
TipRanks·09/02 11:45
cbdMD enters definitive agreement to acquire Twinlab Brands
Dow Jones·09/02 11:36
Press Release: cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness
Dow Jones·09/02 11:36
*CbdMD Enters Definitive Agreement To Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss And Longevity Wellness >YCBD
TipRanks·08/26 00:13
CbdMD Inc. Earnings Call Balances Growth and Risk
Dow Jones·08/17 12:46
cbdMD Cut to Hold From Buy by Maxim Group
TipRanks·08/17 12:11
cbdMD downgraded to Hold from Buy at Maxim
Dow Jones·08/13 20:14
*CbdMD: Introducing a Zero-Proof Kava Beverage Under Oasis Brand >YCBD
Dow Jones·08/13 20:10
Press Release: cbdMD Reports 20% Year-over-Year -2-
Seeking Alpha·08/13 16:47
Here are the major earnings after the close Thursday
TipRanks·07/09 12:35
cbdMD’s Bluebird Botanicals announces official partnership with Denver Audubon
TipRanks·07/07 12:40
cbdMD completes self-affirmed GRAS determination supporting CBD consumption

Same Industry

Name/Symbol

Change%

Price

Cbdmd Inc

YCBD

+1.96%

0.4680

McKesson

MCK

-0.31%

866.64

Biogen Inc

BIIB

-1.62%

215.50

Amgen Inc

AMGN

+1.55%

385.65

Shire

SHPG

0.00%

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

+7.67%

0.1249

Lilly Eli & Co

LLY

+1.04%

Celgene

CELG

0.00%

108.24

Therapeuticsmd Inc

TXMD

0.00%

2.030

Johnson & Johnson

JNJ

-0.09%

269.99

Abbvie Inc

ABBV

+0.35%

266.69

Zoetis Inc

ZTS

-0.74%

70.87

Gilead Sciences Inc

GILD

-0.52%

150.11

NVO

Bristol-Myers Squibb Co

BMY

+0.35%

63.06

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

-2.10%

27.53

Sanofi FR

SNY

+0.42%

41.11

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-0.39%

140.37

Dr Reddys Labs

RDY

0.00%

12.19

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.